phosphonic acid and Renal Insufficiency, Chronic

phosphonic acid has been researched along with Renal Insufficiency, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akiba, T; Akizawa, T; Fukagawa, M; Kuwabara, M; Shigematsu, T; Tsuchiya, A; Yokoyama, K; Yoshikawa, K	1

Other Studies

1 other study(ies) available for phosphonic acid and Renal Insufficiency, Chronic

Article	Year
Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan. Clinical and experimental nephrology, 2021, Volume: 25, Issue:1 Topics: Administration, Intravenous; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Female; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Japan; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorous Acids; Product Surveillance, Postmarketing; Renal Dialysis; Renal Insufficiency, Chronic	2021

Article

Year

Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan.

Clinical and experimental nephrology, 2021, Volume: 25, Issue:1

Topics: Administration, Intravenous; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Female; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Japan; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorous Acids; Product Surveillance, Postmarketing; Renal Dialysis; Renal Insufficiency, Chronic

2021